成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Myricananin A

Myricananin A Struktur
1079941-35-7
CAS-Nr.
1079941-35-7
Englisch Name:
Myricananin A
Synonyma:
Xylomycin A;Myricananin A;PubChem ID: 25141365;Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaene-3,8,9,17-tetrol, 16-methoxy-, (8R,9R)-rel-(+)-
CBNumber:
CB22519883
Summenformel:
C20H24O5
Molgewicht:
344.41
MOL-Datei:
1079941-35-7.mol

Myricananin A Eigenschaften

Siedepunkt:
596.7±50.0 °C(Predicted)
Dichte
1.277±0.06 g/cm3(Predicted)
pka
9.38±0.60(Predicted)

Sicherheit

Myricananin A Chemische Eigenschaften,Einsatz,Produktion Methoden

Myricananin A Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Myricananin A Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 25)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Jusheng Technology Co.,Ltd. 		18871490254
linda@hubeijusheng.com CHINA 28172 58
Labnetwork lnc. 		+86-27-50766799 +8618062016861
 contact@labnetwork.com China 19987 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38631 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd 		+86-18791163155 +86-13119157289
 13119157289@163.com China 2973 58
BioBioPha Co., Ltd. 0871-65217109 13211707573;
 y.liu@mail.biobiopha.com China 5653 65
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
 sales@reading-chemicals.com China 15178 58
Wuhan ChemFaces Biochemical Co., Ltd. 18607101326 15172504745
 aileen@chemfaces.com China 6905 55
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8447 60
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
 info@efebio.com China 9806 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
 3008007409@qq.com China 27313 60

1079941-35-7()Verwandte Suche:

  • Myricananin A
  • PubChem ID: 25141365
  • Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaene-3,8,9,17-tetrol, 16-methoxy-, (8R,9R)-rel-(+)-
  • Xylomycin A
  • 1079941-35-7
Copyright 2019 ? ChemicalBook. All rights reserved